Dr Gregory Obert, PHD, LCPC in Madison, MS - Psychologist

Dr Gregory Obert, PHD, LCPC is a Psychologist - Clinical based in Madison, Mississippi. Dr Gregory Obert is licensed to practice in Mississippi (license number 641183) and his current practice location is 7570 Old Canton Rd Ste 102, Madison, Mississippi. He can be reached at his office (for appointments etc.) via phone at (601) 809-5324.

NPI number for Dr Gregory Obert is 1063863629 and his current mailing address is 7570 Old Canton Rd Ste 102, Madison, Mississippi. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1063863629.

Contact Information

	Dr Gregory Obert, PHD, LCPC
	7570 Old Canton Rd Ste 102, Madison, MS 39110-6100
	(601) 809-5324
	Not Available

Healthcare Provider's Profile

Full Name	Dr Gregory Obert
Gender	Male
Speciality	Psychologist - Clinical
Location	7570 Old Canton Rd Ste 102, Madison, Mississippi
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1063863629
Provider Enumeration Date: 06/24/2016
Last Update Date: 01/17/2024

Medical Identifiers

Medical identifiers for Dr Gregory Obert such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1063863629	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YM0800X	Counselor - Mental Health	180013378 (Illinois)	Secondary
103TC0700X	Psychologist - Clinical	641183 (Mississippi)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Gregory Obert is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Gregory Obert, PHD, LCPC 7570 Old Canton Rd Ste 102, Madison, MS 39110-6100 Ph: (601) 809-5324	Dr Gregory Obert, PHD, LCPC 7570 Old Canton Rd Ste 102, Madison, MS 39110-6100 Ph: (601) 809-5324

News Archive

Health Impact Project announces $400,000 in grants to 4 organizations to conduct health impact assessments

The Health Impact Project, a collaboration of the Robert Wood Johnson Foundation and The Pew Charitable Trusts, today announced nearly $400,000 in grants to four organizations to conduct health impact assessments (HIAs). The assessments will identify and address potential and often overlooked health implications of policy proposals including farm-to-school food legislation, energy development, smart-metering technology for electric utilities and urban transportation plans.

Simple text messages can help teenagers lose weight

Texts committing obese teenagers to eat a small bowl of cereal each day or fruit for dessert saw them eight times more likely to keep their weight down.

World Bank has approved a US$68 million credit to the Indian government for the Integrated Disease Surveillance project

India has made major gains in control of a number of communicable diseases and in improving overall health of its population. Nevertheless, with the increasing age profile of the population, India is in transition with the double burden of significant communicable diseases and increasing non-communicable diseases such as cardio-vascular diseases, cancers, diabetes and cataract blindness, maladies that usually affect higher income countries.

Specialized high volume centers linked with lower rates of death and disability from aSAH

People with bleeding brain aneurysms have the best chance of survival and full recovery if they receive aggressive emergency treatment from a specialized team at a hospital that treats a large number of patients like them every year, according to new guidelines just published by the American Stroke Association.

ETEX receives FDA marketing clearance for CarriGen Porous Bone Substitute Material

ETEX Corporation, an advanced biomaterials company, announced today that the FDA has granted 510(k) clearance of CarriGen® Porous Bone Substitute Material. CarriGen is available for immediate sale through ETEX's independent sales force. CarriGen builds upon the clinically proven benefit of ETEX nanocrystalline calcium phosphate technology by adding the advantage of increased porosity and pore size. CarriGen is the first highly porous bone graft substitute that sets hard upon implantation for a complete defect fill.

Dr Gregory Obert, PHD, LCPC - Counselor in Madison, MS